On January 8, 2020 Checkmate Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused upon activation of innate immunity to treat cancer, reported that it will make a presentation at the 38th Annual J.P. Morgan Healthcare Conference (Press release, Checkmate Pharmaceuticals, JAN 8, 2020, View Source [SID1234552864]). The company will provide a corporate update on Wednesday, January 15, 2020 at 4:30 pm PT at the Westin St. Francis in San Francisco.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!